Sign in

NCT07203222Completed

Comparison of Effectiveness of Low Dose Laser and Transcutaneous Electrical Stimulation in Hemiplegic Shoulder

Comparison of the Efficacy of Low-Dose Laser and Transcutaneous Electrical Nerve Stimulation in Subacute Hemiplegic Shoulder Pain, and the Effect of Treatments on Upper Extremity Function and Quality of Life

Source: ClinicalTrials.gov · Last updated 30 Oct 2026

Brief summary (registry, in English)

The primary aim of this study is to compare the efficacy of Transcutaneous Electrical Nerve Stimulation (TENS) and Low Level Laser Therapy (LLLT), which are analgesic modalities that play an important role in the treatment of this frequently encountered complication. The secondary aim of the study is to evaluate its effectiveness on upper extremity function, quality of life, sleep, and fatigue.

Status (registry)
Completed
Study type
Interventional
Enrollment
45 (actual)
First submitted
24 Sept 2025
Start date
24 Sept 2025
Primary completion date
30 Jul 2026
Lead sponsor
Ankara Etlik City Hospital
Diseases
Stroke
NCT number
NCT07203222

What you commit to

  • Study type: Interventional
  • Participants enrolled: 45
  • From 24 Sept 2025 to the primary completion date, 30 Jul 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients who have undergone shoulder injury and surgery prior to stroke
  • Alcohol and drug addiction

Other illness

  • Inflammatory rheumatic disease
  • Patients with other conditions that could explain shoulder pain
  • Patients with complex regional pain syndrome
  • Patients with a history of epilepsy, pacemaker, or arrhythmia diagnosis
  • Malignancy
  • Diseases such as Alzheimer's or dementia that cause cognitive impairment -History of psychiatric disorders such as major depression or personality disorders

Age

  • Being under 18 years of age

Other

  • Patients who refuse to provide written consent or attend follow-up visits
  • Patients with motor aphasia
  • Patients who have had a shoulder injection within the last 3 months
  • Patients who have undergone upper extremity botulinum toxin application within the last 6 months
    • \*Pregnant women or those planning to become pregnant

Who the study is looking for

  • Patients aged 18-75 years
  • Patients with shoulder pain on the hemiplegic side \*Mini mental state examination ≥ 25
  • History of stroke within the last 2 weeks to 6 months
  • Patients with shoulder pain scoring 40-100 points on the visual analogue scale (moderate to severe) will be included.

Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Ankara Etlik City Hospital
Coordinator of this site? Confirm its status
AnkaraTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.